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Phenotypic switching of antibiotic resistance circumvents
permanent costs in Staphylococcus aureus
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Bacterial antibiotic resistance is often associated with characterized by a slow growth rate, absence of pigmenta-
a fitness cost in the absence of the antibiotic [1, 2]. tion, a reduced range of carbohydrate utilization, and fail-
We have examined a resistance mechanism in ure to express several putative virulence factors [7]. SCVs
Staphylococcus aureus that negates these costs. have previously been considered to represent a small sub-
Exposure to gentamicin both in vitro and in vivo has population of organisms that become auxotrophs follow-
been reported to result in the emergence of a ing the acquisition of a mutation in genes involved in the
gentamicin-resistant small colony variant (SCV) [3–8]. electron transport chain. There are two classes of SCV,
We show that the emergence of SCVs following those that are stable following serial passage, or those that
exposure to gentamicin results from a rapid switch can revert back to having wild-type growth characteristics
and that bacteria exposed to cycles of gentamicin [8]. They have been reported to arise after uptake of
followed by antibiotic-free medium repeatedly bacteria by endothelial cells in vitro [9], following expo-
switched between a resistant SCV and a sensitive sure to gentamicin in broth culture [10], and during human
parental phenotype (revertants). The fitness of or experimental infection [11–14]. The significance of
revertants relative to S. aureus with stable SCVs for human infection is that they are associated with
gentamicin resistance was greater in drug-free media, cases of S. aureus infection that prove to be resistant to
which suggests that S. aureus has evolved an antibiotic cure, manifested by persistence or relapse.
inducible and reversible resistance mechanism that
circumvents a permanent cost to fitness. The rate of emergence of SCVs upon exposure to genta-
micin was determined for five independent isolates ofAddresses: *Nuffield Department of Clinical Laboratory Sciences,
S. aureus, all from cases of severe community-acquiredUniversity of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU,
United Kingdom. †Department of Biology and Biochemistry, University disease. Bacteria were grown in a laboratory growth me-
of Bath, Bath BA2 7AY, United Kingdom. dium (BHI, brain heart infusion) containing gentamicin,
and the number of SCVs as a percentage of the populationCorrespondence: Ruth C. Massey
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a time course. Surprisingly, SCVs were present after only
Received: 25 July 2001 30 min of exposure to gentamicin and made up more than
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proportion of SCVs reached a peak at 14 hr, subsequently
Published: 13 November 2001 declining with the emergence and outgrowth of gentami-
cin-resistant strains with wild-type characteristics. Stable
Current Biology 2001, 11:1810–1814 resistance to gentamicin can result from point mutations
of the genes encoding target proteins, and the emergence0960-9822/01/$ – see front matter
 2001 Elsevier Science Ltd. All rights reserved. we see is consistent with normal mutation rates in combi-
nation with selection by the presence of gentamicin.
We examined whether the rate of emergence of SCVs couldResults and Discussion
be explained by growth from the original inoculating popula-The acquisition of antibiotic resistance through genetic
tion using two strategies. The frequency of SCVs in themutation is frequently associated with a fitness cost in
population before exposure to gentamicin was found to bethe absence of the antibiotic [1, 2]. The evolution of
less than 105. In order to reach the frequency observed atfitness-compensatory mechanisms through second-site
30 min, the SCVs would need to have a mean generationmutations has been defined in bacteria during serial pas-
time of approximately 3min, and over 7 hr, themean genera-sage in broth culture or experimental animals, but the
tion time would have to be 28 min. However, the actualrelative fitness of the resulting strains often remains re-
mean generation time over 7 hr under the same conditionsduced [2–4]. A reversible antibiotic resistance mechanism
was found to be 3.5 hr. The second strategy was based onthat is not associated with a potentially lasting fitness cost
the fact that, if the emergence of SCVs depended on theiris likely to be favored by selection.
presence in the inoculum, reducing the numbers of bacteria
introduced into the gentamicin broth should reduce theirPhenotypic variants of Staphylococcus aureus, known as
frequencywithin thepopulation.After reducing thebacterialsmall colony variants (SCVs), are believed to have a defect
inoculum 100-fold, the proportion of SCVs in the populationin electron transport and are resistant to aminoglycosides
by virtue of poor drug uptake [5, 6]. These variants are after 24 hr of incubation increased from 32%  4.5% to
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Figure 1
The effect on the growth of S. aureus upon
exposure to gentamicin. (a) A growth curve
of S. aureus in the presence or absence of a
sublethal dose of gentamicin. The data is
represented as the mean cfu/ml for five S.
aureus strains  standard error of the mean.
(b) A graph showing the emergence of SCVs
(as a percentage of the total population) after
exposure to gentamicin over 24 hr. The data
is represented as the mean value for five S.
aureus strains  standard error of the mean.
68.8% 14% (p 0.001). This is consistent with switching switching through cyclical exposure to gentamicin and gen-
tamicin-free media five times (Figure 2). This unequivo-to the SCV phenotype combined with a decreased chance
of including stable gentamicin-resistant mutants in the inoc- cally demonstrates a mechanism by which S. aureus can
switch between gentamicin-sensitive and gentamicin-resis-ulum. Together, these data suggest that the SCVs cannot
have emerged as a result of the replication of existing variants tant forms. We extended our analysis to 30 independent
isolates of S. aureus associated with either nasal carriage inin the inoculating population and must have emerged by
switching from the wild-type to the SCV phenotype. healthy volunteers (n  15) or invasive disease (n  15,
inclusive of the 5 initial isolates). The emergence of SCVs
was demonstrated for all isolates, suggesting that thismech-To test whether this was a two-way and repeatable switch,
we picked SCVs from each of the five original isolates anism is common within natural populations of S. aureus.
and exposed them to antibiotic-free media. In all cases,
SCV clones were found to spontaneously revert to the wild- Having established the existence of a switching mecha-
nism, we next determined whether the switch was spon-type phenotype. Rechallenge of revertant clones with
gentamicin resulted in the emergence of SCVs at the taneous or induced by gentamicin. No SCVs were ob-
served at any time during 24 hr of growth in the absencesame frequency as from the original wild-type population.
This phenomenon was fully repeatable with induction of of gentamicin, supporting the hypothesis of an inducible
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Figure 2
Phenotypic switching of S. aureus in response
to the presence or absence of gentamicin.
(A) A graph showing the switch to the SCV
phenotype of a population of wild-type (WT)
bacteria following exposure to gentamicin
(Ab). (B) A graph showing the switch back
to wild-type phenotype (revertants: REV) of
populations of SCVs following removal of
gentamicin (Ab) from the environment. (C)
A graph showing the switch to the SCV
phenotype (SCVa) of a population of revertant
(REV) bacteria following exposure to
gentamicin (Ab). (D) A graph showing the
switch back to wild-type phenotype (REVa)
of populations of SCVa following removal of
gentamicin (Ab) from the environment. (E)
A graph showing the switch to the SCV
phenotype (SCVb) of a population of REVa
bacteria following exposure to gentamicin
(Ab). (F) A graph showing the switch back
to wild-type phenotype (REVb) of populations
of SCVb following removal of gentamicin
(Ab) from the environment. The data is
represented as the mean percentage of SCV
in the population for five S. aureus strains 
standard error of the mean.
switch. However, high-frequency spontaneous switching mycin or spectinomycin. It is possible that only certain
members of the aminoglycoside family can induce switch-and antibiotic-imposed selection of resistant SCVs might
ing to SCVs or that concentrations other than the MICexplain these data if the rate of switching from wild-type
may be required to induce this switching event. We exam-to SCV was lower than the rate of switching from SCV to
ined the effects of varying the concentration of gentamicinrevertant. Our estimates suggest that the rate of switching
on the emergence of SCVs. The MIC of SCV was foundfrom wild-type to SCV (95% confidence interval [CI]:
to be 20-fold higher than wild-type/revertants (which had0.07%–0.3% cells/generation) is at least an order of magni-
the sameMICs). Growth in concentrations above theMICtude greater than the rate of switching from an SCV to a
of SCV resulted in death of the entire inoculum, whilerevertant (95% CI: 0.0009%0.04% cells/generation). We
the emergence of SCVs was favorably selected by a con-therefore consider it unlikely that our data can be ex-
centration between the MIC of wild-type and SCV. Con-plained by a high-rate switch that usually favors the sensi-
centrations below the MIC of wild-type initially inducedtive variant in the absence of gentamicin, but which allows
switching, but by 24 hr, the SCVs were outgrown byselection and capture of the resistant population in the
sensitive wild-type. It has been suggested previously thatpresence of gentamicin. Whether or not the switch from
the SCV phenotype confers increased resistance to otherSCV to revertant is spontaneous or induced by the absence
antibiotics [17]. We found that SCVs were no more resis-of antibiotic is as yet unclear.
tant to methicillin, vancomycin, erythromycin, ciprofloxa-
cin, rifampicin, fusidic acid, and tetracycline.
To examine whether stresses other than gentamicin in-
duce switching to SCVs, the five S. aureus isolates were We next consideredwhether the ability to switch between
grown under either acidic, oxidative, anaerobic, starvation, gentamicin-resistant and -sensitive forms provided a fit-
or temperature stress. SCVs were not induced by these ness advantage over mutants of S. aureus that are stably
conditions. Consistent with this was the finding that the resistant to gentamicin. Mutants with stable gentamicin
general stress-response sigma factor SigB did not play a resistance were isolated from the five S. aureus isolates
role in the switching mechanism, as a strain deficient in and were found to have a 40-fold increase in MIC relative
SigB switched to the same degree as its parent (SigB) to wild-type. SCVs had a growth rate disadvantage relative
strain [15]. Bacteria were also grown in the minimum to the stable mutants when grown in the presence of
inhibitory concentration (MIC) [16] of either methicillin, gentamicin, as can be seen in Figure 1 by the outgrowth
vancomycin, erythromycin, ciprofloxacin, chlorampheni- of SCVs by resistant mutants after 14 hr of exposure
col, streptomycin, spectinomycin, amikacin, kanamycin, to gentamicin. However, gentamicin-sensitive revertants
or tobramycin. The only conditions tested that led to outcompeted stable gentamicin-resistant strains when
grown in antibiotic-free media where the stable mutantsswitching to SCVs was growth in the presence of strepto-
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had a relative fitness of 0.44 (standard error of 0.05; paired Our second proposedmechanism is that a recombinational
switch is causing an alteration at the level of DNA se-t test, p  0.0001) [18]. We next examined whether the
ability to switch during cycling conditions in the presence quence. The frequency of recombination causing the
phase-variation of the type 1 fimbriae of E. coli can beor absence of gentamicin was sufficient to allow the re-
vertant phenotype to dominate once the antibiotic was directionally modulated in response to alterations in the
level of DNA supercoiling, which in itself is caused bypermanently removed. After two successive cycles in the
presence and absence of gentamicin, 54% (15%) of the many environmental factors [20]. We propose that amino-
glycosides, either directly or indirectly, may induce a re-population was found to be sensitive to gentamicin. By
adopting the SCV phenotype on exposure to gentamicin, combination event resulting in the SCV phenotype. The
long-term association between S. aureus and aminoglyco-S. aureus acquires antibiotic resistance together with a
reduced rate of growth. The removal of gentamicin from side-producing microbes and the fitness costs associated
with permanent antibiotic resistance make the evolutionthe bacterial environment induces bacteria to revert to
the wild-type phenotype, and, in so doing, avoids the by natural selection of such an environmentally induced
recombination event feasible.acquisition of a fitness disadvantage associated with resis-
tance by mutation.
Materials and methods
Gentamicin is not routinely used to treat serious S. aureus SCV emergence assays
BHI (brain heart infusion) broth containing the published breakpoint MICinfections [19], and so the use of gentamicin as a therapeutic
of gentamicin, 2 g/ml (GIBCO BRL,) was inoculated with 5 106 cfu/agent is unlikely to have been the selective force responsi-
ml (colony forming units/ml) of S. aureus strains that had grown overnight
ble for the evolution of the switchingmechanism.Gentami- at 37C in air on horse blood agar. The broth cultures were incubated
cin is naturally produced by Micromonaspora species, and with constant rotation in air at 37C. Aliquots were removed at allotted
time points, serially diluted, and plated onto antibiotic-free blood agar.streptomycin and spectinomycin are produced by Strepto-
SCVs were identified by having a colony size a tenth of the size of amyces species, so we hypothesize that long-term interactions
normal colony and having no pigmentation or hemolytic activity. Thewith such species has selected for this switching mecha- percentage of the population that consisted of SCVs was counted after
nism. This is consistent with the fact that S. aureus was 24 hr of growth at 37C. The data shown is the mean percentage for
the five independent strains. Error bars indicate the standard error ofknown to have evolved penicillin resistance by the time
the mean.the drug was discovered, presumably again in response to
interactions betweenmicrobial species in the environment.
Frequency of SCVs in an unstressed populationEvolutionary development of this switch suggests that
To measure the prevalence of SCVs in a population of S. aureus, bacteria
other bacterial pathogens may have evolved similar strate- were grown overnight on blood agar at 37C. The bacteria were diluted
gies, a possibility that merits investigation. and plated onto fresh blood agar such that individual colonies of SCVs,
if present, could be identified, i.e.: 200–500 cfu/plate. A total of 105 cfu
were plated, and no SCVs were identified.These data provide the first demonstration that bacteria
can switch between antibiotic-resistant and -sensitive
Growth rate of SCVsforms in response to antibiotic pressure. We are working The frequency of SCVs in the inoculating population is  105, so if we
to elucidate themechanism, but it is currently unclear how assign this a value of 106, the number of SCVs introduced into the BHI
it compares with other phenotypic switches in bacteria. In with gentamicin was 5 cfu/ml. After 30 min, the SCV make up 0.1% of
1.4 106 cfu/ml. The number of doublings from 5 to 1.4 103 is approxi-the absence ofmechanistic detail, we propose twomodels.
mately 8, resulting in a mean generation time after 30 min of exposure toThe first is that an epigenetic event occurs and alters
gentamicin of 3.75 min. After 7 hr, the SCV make up 27% of 5  105
the regulation of a subset of genes, resulting in the SCV cfu/ml, which is 1.4  105 cfu/ml. The number of doublings from 5 to
phenotype. Although SCVs revert once gentamicin is re- 1.4  105 is approximately 15. Therefore, the mean generation time for
SCVs to have grown from the inoculating population over 7 hr would bemoved, it is not an immediate or a population-wide event,
28 min. SCVs from each of the five S. aureus strains were grown overnightand so the possibility that a regulatory change could con-
at 37C on blood agar. BHI containing 2 g/ml gentamicin was inoculatedtinue to exert effects through several generations is intri- with 1  106 SCVs cfu/ml; after 7 hr of incubation, the cfu/ml for each
guing. For this to be true, the effector protein would strain was estimated by diluting and plating onto fresh blood agar and was
found to be 4.2  106 (3  105). This suggests that SCVs grown inneed to have an extremely long half-life to result in the
BHI with gentamicin have a mean generation time of 3.5 hr.observed maintenance of the phenotype once gentamicin
is removed. It would also need to be highly active at very
Reversion assaylow concentrations, such that titration following multiple
The experiment to measure the rate of switching from SCV to revertant
cell divisions ultimately leads to a state in which the phenotype was carried out as described above for the SCV emergence
threshold concentration for activity is maintained in one assay with the following exceptions: the BHI broth contained no antibiot-
ics; the inoculating population consisted of SCVs; and the assay wasdaughter cell (which maintains the SCV phenotype) but
continued for an additional 24 hr.lost in another (resulting in reversion), thereby explaining
why reversion is not population wide. We do not believe
Estimation of switching ratesa protein with such activity has previously been character- Accurately estimating the rate of switching (% cells/generation) from wild-
ized and suggest that this would be a novel mechanism type to SCV is problematic because the generation time of the wild-type
may be extended indefinitely by the antibiotic. We provide a conservativefor antibiotic resistance.
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